Machine could make CAR T-cell therapy more accessible
Researchers have developed a new bioreactor that can manufacture T cells faster than other technologies, which may advance immunotherapy.
List view / Grid view
Researchers have developed a new bioreactor that can manufacture T cells faster than other technologies, which may advance immunotherapy.
Researchers have found that reducing glycosylation on the T cell surface may offer new approaches to cancer immunotherapy.
Researchers have discovered a molecule that binds to a cancer cell protein, stopping growth of breast and ovarian tumours.
A new small molecule has great promise for the treatment of autoimmune diseases by inhibiting the proinflammatory signalling pathway.
Researchers found surprising function of pulmonary ionocytes which may affect how cystic fibrosis drugs work.
An epitope on CD95 receptor causes tumour cells to self-destruct and may prolong benefits of CAR T-cell therapy for solid tumours.
Scientists have developed ExoCaps, self-healing microcapsules that are more feasible than other cell-based technologies.
Lactate producing bacteria is responsible for rewiring metabolic signalling pathways, causing resistance to radiation therapy.
Extracellular vesicles loaded with mRNA encoding interferon-gamma offers promise for treating difficult tumours.
3D tumour models enable scientists to offer better treatments and improve survival outcomes for complex conditions like breast cancer.
Bacteria programmed to paint targets on solid tumours for T cells to see eliminates the need for specific antigens.
Discovery about Huntington’s disease may apply to other neurodegenerative disorders, like Alzheimer’s and frontotemporal dementia.
Researchers designed the first magnetoelectric material that precisely stimulates neurons to treat nerve damage.
A new discovery about a different protective genetic mutation in apolipoprotein L1 could have major implications for kidney health.
New research improves patient care by finding where gene copies integrate into DNA and using lentiviral vectors.